Pharmaceutical giant Astra Zeneca has agreed to settle a gender pay bias claim, and the consent decree that spells out the terms of the settlement could affect North Carolina women who work for the company.
Under the settlement, 124 female pharmaceutical sales specialists will split $250,000.
A Department of Labor (DOL) investigation revealed that the women’s salaries averaged $1,700 less than their male counterparts.
As part of the settlement with the DOL’s Office of Federal Contract Compliance Programs, Astra Zeneca must also conduct a statistical analysis of the base pay of 415 individuals employed full time as “primary care” and “specialty care” level III pharmaceutical sales specialists in North Carolina and 12 other states and the District of Columbia. If the analysis concludes that the women continue to be underpaid, the company will adjust salaries accordingly.
Astra Zeneca must also update its affirmative action plan and maintain all appropriate documentation.
Like what you've read? ...Republish it and share great business tips!
Attention: Readers, Publishers, Editors, Bloggers, Media, Webmasters and more...
We believe great content should be read and passed around. After all, knowledge IS power. And good business can become great with the right information at their fingertips. If you'd like to share any of the insightful articles on BusinessManagementDaily.com, you may republish or syndicate it without charge.
The only thing we ask is that you keep the article exactly as it was written and formatted. You also need to include an attribution statement and link to the article.
" This information is proudly provided by Business Management Daily.com: http://www.businessmanagementdaily.com/14123/settlement-may-mean-higher-pay-for-pharma-firms-nc-women "